Overall Status

Completed (16)

Approved for marketing (3)

No longer available (3)

Terminated (3)

Recruiting (1)

Unknown status (1)

Withdrawn (1)

Phase

phase 2 (7)

n/a (4)

phase 1 (2)

phase 1/phase 2 (2)

phase 2/phase 3 (2)

phase 3 (2)

phase 4 (2)

Collaborator

Boston Children's Hospital (1)

Children's Hospital and Medical Center, Omaha, Nebraska (1)

Fresenius Kabi (1)

OU Medical Center (1)

St. Louis University (1)

The Hartwell Foundation (1)

University of Nebraska (1)

Intervention

omegaven (28)

intralipid (2)

cytarabine (1)

daunorubicin (1)

isotonic saline (1)

placebo (1)

soybean oil lipid emulsion (1)

standard lipids (primarily omega-6 fatty acids) (1)

Study Documents

Intervention Type

drug (28)

dietary supplement (1)

Funder Type

Other (28)

Study Type

Interventional (21)

Expanded Access (6)

Observational (1)

omegaven

Showing 26 - 28 of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Tumor, Gastric Tumor Trial in Leicester (Omegaven)

Terminated

Esophageal Neoplasm
Gastric Neoplasm

Omegaven

Leicester, Leicestershire, United Kingdom

University Hospitals of Leicester NHS Trust

May 25, 2016

Cholestasis Trial in Urbana (Omegaven)

Unknown status

Cholestasis

Omegaven

Urbana, Illinois

Carle Foundation Hospital

Jan 7, 2015

Ventricular Tachycardia, Sudden Cardiac Death Trial in Aalborg (Omegaven, Isotonic saline)

Completed

Ventricular Tachycardia
Sudden Cardiac Death

Omegaven
Isotonic saline

Aalborg, Denmark

Department of Cardiology, Aalborg Hospital

Apr 15, 2015